Literature DB >> 33665211

Mitigating the Risk of COVID-19 Deaths in Cardiovascular Disease Patients in Africa Resource Poor Communities.

Ihunanya Chinyere Okpara1, Efosa Kenneth Oghagbon2.   

Abstract

The novel coronavirus disease 2019 (Covid-19) pandemic has affected millions of patients in almost all countries with over one million cases recorded in Africa where it is a major health challenge. Covid-19 is known to have significant implications for those with pre-existing cardiovascular disease (CVD) and their cardiologists. Patients with pre-existing CVD are at increased risk of morbidity and mortality from Covid-19 due to associated direct and indirect life threatening cardiovascular (CV) complications. Mitigating the risk of such Covid-19 deaths in resource poor communities requires the institution of preventive measures at the primary, secondary and tertiary levels of preventive phenomenon with emphasis at the first two levels. General preventive measures, screening and monitoring of CVD patients for complications and modification of drug treatment and other treatment methods will need to be implemented. Health policy makers and manager should provide required training and retraining of CV health care workers managing Covid-19 patients with CVD, provision of health education, personal protective equipment (PPE), and diagnostic kits.
Copyright © 2021 Okpara and Oghagbon.

Entities:  

Keywords:  Africa; COVID-19 deaths; cardiovascular disease; levels of prevention; resource poor communities

Year:  2021        PMID: 33665211      PMCID: PMC7920970          DOI: 10.3389/fcvm.2021.626115

Source DB:  PubMed          Journal:  Front Cardiovasc Med        ISSN: 2297-055X


  44 in total

Review 1.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  J Am Coll Cardiol       Date:  2018-08-25       Impact factor: 24.094

Review 2.  Chloroquine cardiomyopathy - a review of the literature.

Authors:  Ernst Tönnesmann; Reinhard Kandolf; Thorsten Lewalter
Journal:  Immunopharmacol Immunotoxicol       Date:  2013-05-01       Impact factor: 2.730

3.  Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate.

Authors:  Elisabeth Mahase
Journal:  BMJ       Date:  2020-02-18

4.  COVID-19 and the cardiovascular system.

Authors:  Ying-Ying Zheng; Yi-Tong Ma; Jin-Ying Zhang; Xiang Xie
Journal:  Nat Rev Cardiol       Date:  2020-05       Impact factor: 32.419

5.  Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis.

Authors:  Sheng Zhang; MengYuan Diao; Wenbo Yu; Lei Pei; Zhaofen Lin; Dechang Chen
Journal:  Int J Infect Dis       Date:  2020-02-22       Impact factor: 3.623

6.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.

Authors:  Ning Tang; Dengju Li; Xiong Wang; Ziyong Sun
Journal:  J Thromb Haemost       Date:  2020-03-13       Impact factor: 5.824

Review 7.  Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China.

Authors:  Bo Li; Jing Yang; Faming Zhao; Lili Zhi; Xiqian Wang; Lin Liu; Zhaohui Bi; Yunhe Zhao
Journal:  Clin Res Cardiol       Date:  2020-03-11       Impact factor: 6.138

8.  Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.

Authors:  Frederick G P Welt; Pinak B Shah; Herbert D Aronow; Anna E Bortnick; Timothy D Henry; Matthew W Sherwood; Michael N Young; Laura J Davidson; Sabeeda Kadavath; Ehtisham Mahmud; Ajay J Kirtane
Journal:  J Am Coll Cardiol       Date:  2020-03-19       Impact factor: 24.094

9.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.